We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

27 hedge funds and large institutions have $76M invested in BioAmber Inc. in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 2

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

52% more capital invested

Capital invested by funds: $50.2M → $76M (+$25.8M)

13% more funds holding

Funds holding: 24 → 27 (+3)

7.77% more ownership

Funds ownership: 27.16% → 34.93% (+7.8%)

Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
2
Closed
5
Calls
$1.04M
Puts
–
Net Calls
+$1.04M
Net Calls Change
-$45K

BIOA Hedge Fund Activity: Q3 2014 in Review

27 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q3 2014, worth a combined $76M — up 52% from $50.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIOA positions and 5 closed out — a net gain of 3 holders — while 14 added to existing stakes and 2 trimmed.

The largest buyer was Waddell & Reed Financial, adding an estimated $17.1M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $398K sold.

  • 27 institutional investors held BioAmber Inc. (BIOA) as of Q3 2014, up from 24 in Q2 2014.
  • Funds reported $76M of BioAmber Inc. stock for Q3 2014, up 52% quarter-over-quarter.
  • 8 funds opened new BioAmber Inc. positions in Q3 2014 and 5 closed out, a net change of +3 holders.
  • The largest BioAmber Inc. buyer in Q3 2014 was Waddell & Reed Financial, an estimated $17.1M added.
  • The largest BioAmber Inc. seller in Q3 2014 was Renaissance Technologies, an estimated $398K sold.

Based on aggregated 13F filings for Q3 2014.